Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial).

Clarke JM, Blobe GC, Strickler JH, Uronis HE, Zafar SY, Morse M, Dropkin E, Howard L, O'Neill M, Rushing CN, Niedzwiecki D, Watson H, Bolch E, Arrowood C, Liu Y, Nixon AB, Hurwitz HI.

Cancer Chemother Pharmacol. 2019 Oct;84(4):909-917. doi: 10.1007/s00280-019-03916-0. Epub 2019 Aug 23.

2.

The Amount of Evidence Needed to Support ERBB2 as a Biomarker for Resistance to EGFR Inhibitors in Metastatic Colorectal Cancer.

Raghav K, Strickler JH.

JAMA Oncol. 2019 Aug 15. doi: 10.1001/jamaoncol.2019.2985. [Epub ahead of print] No abstract available.

PMID:
31415062
3.

Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response.

Turner MC, Keenan JE, Rushing CN, Gulack BC, Nussbaum DP, Benrashid E, Hyslop T, Strickler JH, Mantyh CR, Migaly J.

J Gastrointest Surg. 2019 Aug;23(8):1614-1622. doi: 10.1007/s11605-018-04079-8. Epub 2019 Jan 11.

PMID:
30635829
4.

Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice.

Bekaii-Saab T, Kim R, Kim TW, O'Connor JM, Strickler JH, Malka D, Sartore-Bianchi A, Bi F, Yamaguchi K, Yoshino T, Prager GW.

Clin Colorectal Cancer. 2019 Mar;18(1):e117-e129. doi: 10.1016/j.clcc.2018.11.002. Epub 2018 Nov 16. Review.

5.

Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge.

Parseghian CM, Loree JM, Morris VK, Liu X, Clifton KK, Napolitano S, Henry JT, Pereira AA, Vilar E, Johnson B, Kee B, Raghav K, Dasari A, Wu J, Garg N, Raymond VM, Banks KC, Talasaz AA, Lanman RB, Strickler JH, Hong DS, Corcoran RB, Overman MJ, Kopetz S.

Ann Oncol. 2019 Feb 1;30(2):243-249. doi: 10.1093/annonc/mdy509.

PMID:
30462160
6.

First-in-Human Phase I, Dose-Escalation and -Expansion Study of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, in Patients With Advanced Solid Tumors.

Strickler JH, Weekes CD, Nemunaitis J, Ramanathan RK, Heist RS, Morgensztern D, Angevin E, Bauer TM, Yue H, Motwani M, Parikh A, Reilly EB, Afar D, Naumovski L, Kelly K.

J Clin Oncol. 2018 Nov 20;36(33):3298-3306. doi: 10.1200/JCO.2018.78.7697. Epub 2018 Oct 4. Erratum in: J Clin Oncol. 2019 Jan 20;37(3):261.

PMID:
30285518
7.

Cell-Free DNA Profiling to Discover Mechanisms of Exceptional Response to Cabozantinib Plus Panitumumab in a Patient With Treatment Refractory Metastatic Colorectal Cancer.

Jia J, Morse MA, Nagy RJ, Lanman RB, Strickler JH.

Front Oncol. 2018 Aug 28;8:305. doi: 10.3389/fonc.2018.00305. eCollection 2018.

8.

A within-trial cost-effectiveness analysis of panitumumab compared with bevacizumab in the first-line treatment of patients with wild-type RAS metastatic colorectal cancer in the US.

Graham CN, Christodoulopoulou A, Knox HN, Sabatelli L, Hechmati G, Garawin T, Strickler JH.

J Med Econ. 2018 Nov;21(11):1075-1083. doi: 10.1080/13696998.2018.1510409. Epub 2018 Sep 28.

PMID:
30091652
9.

EGFR Amplification as a Target in Gastroesophageal Adenocarcinoma: Do Anti-EGFR Therapies Deserve a Second Chance?

Strickler JH.

Cancer Discov. 2018 Jun;8(6):679-681. doi: 10.1158/2159-8290.CD-18-0191.

10.

A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours.

Berlin J, Ramanathan RK, Strickler JH, Subramaniam DS, Marshall J, Kang YK, Hetman R, Dudley MW, Zeng J, Nickner C, Xiong H, Komarnitsky P, Shepherd SP, Hurwitz H, Lenz HJ.

Br J Cancer. 2018 Apr;118(7):938-946. doi: 10.1038/s41416-018-0003-3. Epub 2018 Mar 12.

11.

Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer.

Strickler JH, Loree JM, Ahronian LG, Parikh AR, Niedzwiecki D, Pereira AAL, McKinney M, Korn WM, Atreya CE, Banks KC, Nagy RJ, Meric-Bernstam F, Lanman RB, Talasaz A, Tsigelny IF, Corcoran RB, Kopetz S.

Cancer Discov. 2018 Feb;8(2):164-173. doi: 10.1158/2159-8290.CD-17-1009. Epub 2017 Dec 1.

12.

Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches.

Strickler JH, Wu C, Bekaii-Saab T.

Cancer Treat Rev. 2017 Nov;60:109-119. doi: 10.1016/j.ctrv.2017.08.006. Epub 2017 Aug 31. Review.

13.

Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours.

Tachibana M, Papadopoulos KP, Strickler JH, Puzanov I, Gajee R, Wang Y, Zahir H.

Br J Clin Pharmacol. 2018 Jan;84(1):112-121. doi: 10.1111/bcp.13424. Epub 2017 Oct 29.

14.

Clinical applications of liquid biopsies in gastrointestinal oncology.

Zhu J, Strickler JH.

J Gastrointest Oncol. 2016 Oct;7(5):675-686. Review.

15.

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Balaban EP, Mangu PB, Khorana AA, Shah MA, Mukherjee S, Crane CH, Javle MM, Eads JR, Allen P, Ko AH, Engebretson A, Herman JM, Strickler JH, Benson AB 3rd, Urba S, Yee NS.

J Clin Oncol. 2016 Aug 1;34(22):2654-68. doi: 10.1200/JCO.2016.67.5561. Epub 2016 May 31.

PMID:
27247216
16.

Development of a Novel c-MET-Based CTC Detection Platform.

Zhang T, Boominathan R, Foulk B, Rao C, Kemeny G, Strickler JH, Abbruzzese JL, Harrison MR, Hsu DS, Healy P, Li J, Pi C, Prendergast KM, Hobbs C, Gemberling S, George DJ, Hurwitz HI, Connelly M, Garcia-Blanco MA, Armstrong AJ.

Mol Cancer Res. 2016 Jun;14(6):539-47. doi: 10.1158/1541-7786.MCR-16-0011. Epub 2016 Mar 7.

17.

Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.

Roe MT, Cyr DD, Eckart D, Schulte PJ, Morse MA, Blackwell KL, Ready NE, Zafar SY, Beaven AW, Strickler JH, Onken JE, Winters KJ, Houterloot L, Zamoryakhin D, Wiviott SD, White HD, Prabhakaran D, Fox KA, Armstrong PW, Ohman EM; TRILOGY ACS Investigators.

Eur Heart J. 2016 Jan 21;37(4):412-22. doi: 10.1093/eurheartj/ehv611. Epub 2015 Dec 5.

18.

Treatment of High-Grade Metastatic Pancreatic Neuroendocrine Carcinoma with FOLFIRINOX.

Zhu J, Strosberg JR, Dropkin E, Strickler JH.

J Gastrointest Cancer. 2015 Jun;46(2):166-9. doi: 10.1007/s12029-015-9689-0. No abstract available.

PMID:
25662891
19.

Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.

Rangwala F, Bendell JC, Kozloff MF, Arrowood CC, Dellinger A, Meadows J, Tourt-Uhlig S, Murphy J, Meadows KL, Starr A, Broderick S, Brady JC, Cushman SM, Morse MA, Uronis HE, Hsu SD, Zafar SY, Wallace J, Starodub AN, Strickler JH, Pang H, Nixon AB, Hurwitz HI.

Invest New Drugs. 2014 Aug;32(4):700-9. doi: 10.1007/s10637-014-0089-2. Epub 2014 Apr 9.

20.

Gastroesophageal heterotopia and HER2/neu overexpression in an adenocarcinoma arising from a small bowel duplication.

Nussbaum DP, Bhattacharya SD, Jiang X, Cardona DM, Strickler JH, Blazer DG 3rd.

Arch Pathol Lab Med. 2014 Mar;138(3):428-31. doi: 10.5858/arpa.2012-0523-CR.

PMID:
24576036
21.

Palliative treatment of metastatic colorectal cancer: what is the optimal approach?

Strickler JH, Hurwitz HI.

Curr Oncol Rep. 2014;16(1):363. doi: 10.1007/s11912-013-0363-z. Review.

PMID:
24293074
22.

Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer.

Strickler JH, McCall S, Nixon AB, Brady JC, Pang H, Rushing C, Cohn A, Starodub A, Arrowood C, Haley S, Meadows KL, Morse MA, Uronis HE, Blobe GC, Hsu SD, Zafar SY, Hurwitz HI.

Invest New Drugs. 2014 Apr;32(2):330-9. doi: 10.1007/s10637-013-0042-9. Epub 2013 Nov 1.

23.

Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors.

Strickler JH, Starodub AN, Jia J, Meadows KL, Nixon AB, Dellinger A, Morse MA, Uronis HE, Marcom PK, Zafar SY, Haley ST, Hurwitz HI.

Cancer Chemother Pharmacol. 2012 Aug;70(2):251-8. doi: 10.1007/s00280-012-1911-1. Epub 2012 Jun 29.

24.

Bevacizumab-based therapies in the first-line treatment of metastatic colorectal cancer.

Strickler JH, Hurwitz HI.

Oncologist. 2012;17(4):513-24. doi: 10.1634/theoncologist.2012-0003. Epub 2012 Apr 3. Review.

25.

Maintenance therapy for first-line metastatic colorectal cancer: activity and sustainability.

Strickler JH, Hurwitz HI.

Oncologist. 2012;17(1):9-10. doi: 10.1634/theoncologist.2011-0358. Epub 2012 Jan 10. No abstract available.

27.

Three-dimensional optical data storage in refractive media by two-photon point excitation.

Strickler JH, Webb WW.

Opt Lett. 1991 Nov 15;16(22):1780-2.

PMID:
19784138
28.

Two-photon laser scanning fluorescence microscopy.

Denk W, Strickler JH, Webb WW.

Science. 1990 Apr 6;248(4951):73-6.

PMID:
2321027
29.

How many surgeons are needed?

Strickler JH.

Minn Med. 1968 Mar;51(3):331. No abstract available.

PMID:
5649327
30.

Pseudomembranous enterocolitis. A comparison with staphylococcal colitis.

Strickler JH, Rice CO.

Minn Med. 1966 Jun;49(6):899-904. No abstract available.

PMID:
5933702
31.

BREAST PAPILLOMATOSIS.

STRICKLER JH.

Minn Med. 1964 Oct;47:1253-4. No abstract available.

PMID:
14252363
32.

Diagnostic paracentesis.

STRICKLER JH, ERWIN PD, RICE CO.

AMA Arch Surg. 1958 Dec;77(6):859-63. No abstract available.

PMID:
13593980
33.

Fluid, electrolyte and nutritional requirements in the average surgical patient: a statistical analysis.

RICE CO, STRICKLER JH.

Minn Med. 1958 Aug;41(8):557-62. No abstract available.

PMID:
13577635
34.

A statistical analysis of the fluid and electrolyte requirements of surgical patients.

RICE CO, STRICKLER JH, WECKWERTH V.

Am J Surg. 1957 Nov;94(5):727-9. No abstract available.

PMID:
13470169
35.

A day by day analysis of the fluid, electrolyte and nitrogen metabolism as it pertains to parenteral feeding.

RICE CO, STRICKLER JH, WECKWERTH V.

Am J Surg. 1957 Jul;94(1):35-8. No abstract available.

PMID:
13424867
36.

Amino acid solutions for intravenous use; the reduced incidence of systemic reactions when using a low glutamic acid mixture.

RICE CO, STRICKLER JH.

Am J Clin Nutr. 1957 Jan-Feb;5(1):11-3. No abstract available.

PMID:
13394533
37.

The relationship of an elevated blood sugar to an electrolyte imbalance.

RICE CO, STRICKLER JH, AZERIS H.

AMA Arch Surg. 1956 Mar;72(3):508-13. No abstract available.

PMID:
13291979
38.
39.

Parenteral nutrition in surgery.

RICE CO, STRICKLER JH.

SD J Med Pharm. 1956 Jan;9(1):1-7. No abstract available.

PMID:
13290945
40.

Lower nephron nephrosis. II. The function of the kidney when tubular degeneration exists.

RICE CO, STRICKLER JH.

Am J Surg. 1955 Oct;90(4):558-61. No abstract available.

PMID:
13258946
41.

Lower nephron nephrosis. I. A pathogenesis for degeneration of the kidney tubules.

RICE CO, STRICKLER JH, LUFKIN N.

Am J Surg. 1955 Oct;90(4):547-57. No abstract available.

PMID:
13258945
42.

Hyperpotassemia and hyperglycemia; treatment with insulin and invert sugar.

RICE CO, STRICKLER JH.

Minn Med. 1955 Aug;38(8):565-7. No abstract available.

PMID:
13244542
43.

Clinical aspects of fluid and electrolyte management.

STRICKLER JH, RICE CO.

Minn Med. 1955 Mar;38(3):153-64. No abstract available.

PMID:
14369926
44.

Ether flush treatment of retained postoperative common duct stones; a local survey.

STRICKLER JH, ADKINS DC, RICE CO.

Minn Med. 1954 Jul;37(7):490-7. No abstract available.

PMID:
13185168
45.

Degeneration of the kidney tubules (lower nephron nephrosis) associated with electrolyte imbalance; preliminary report.

RICE CO, STRICKLER JH, FERNANDEZ G, LUFKIN N.

Minn Med. 1954 Jun;37(6):421-5. No abstract available.

PMID:
13165371
46.

Parenteral nutrition; adequate parenteral nutrition in general surgery.

RICE CO, STRICKLER JH.

Med Times. 1953 May;81(5):307-14. No abstract available.

PMID:
13054082
47.

Use of polyethylene tubing in intravenous therapy for surgical patients.

ERWIN P, STRICKLER JH, RICE CO.

AMA Arch Surg. 1953 May;66(5):673-8. No abstract available.

PMID:
13039740
48.

An approach toward the ideal in parenteral nutrition.

STRICKLER JH, RICE CO.

Minn Med. 1953 Mar;36(3):221-9. No abstract available.

PMID:
13036782
49.

Parenteral nutrition in elderly surgical patients.

RICE CO, STRICKLER JH.

Geriatrics. 1952 Jul-Aug;7(4):232-40. No abstract available.

PMID:
12980317
50.

Hepatic portal arteriovenous fistula; a case report.

STRICKLER JH, LUFKIN N, RICE CO.

Surgery. 1952 Apr;31(4):583-9. No abstract available.

PMID:
14922105

Supplemental Content

Loading ...
Support Center